25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

HROW (Harrow) Stock Analysis
Buy, Hold or Sell?

Let's analyze Harrow together

I guess you are interested in Harrow Health Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Harrow’s Financial Insights
  • 📈 Technical Analysis (TA) – Harrow’s Price Targets

I'm going to help you getting a better view of Harrow Health Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Harrow Health Inc

I send you an email if I find something interesting about Harrow Health Inc.

1. Quick Overview

1.1. Quick analysis of Harrow (30 sec.)










1.2. What can you expect buying and holding a share of Harrow? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
22.5%

What is your share worth?

Current worth
$1.53
Expected worth in 1 year
$1.43
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$-0.10
Return On Investment
-0.3%

For what price can you sell your share?

Current Price per Share
$31.75
Expected price per share
$25.21 - $32.50
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Harrow (5 min.)




Live pricePrice per Share (EOD)
$31.75
Intrinsic Value Per Share
$-5.16 - $22.73
Total Value Per Share
$-3.63 - $24.26

2.2. Growth of Harrow (5 min.)




Is Harrow growing?

Current yearPrevious yearGrowGrow %
How rich?$56m$56.7m$3.4m5.8%

How much money is Harrow making?

Current yearPrevious yearGrowGrow %
Making money-$5.4m-$7.8m$2.4m44.4%
Net Profit Margin-12.2%-22.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Harrow (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Harrow?

Welcome investor! Harrow's management wants to use your money to grow the business. In return you get a share of Harrow.

First you should know what it really means to hold a share of Harrow. And how you can make/lose money.

Speculation

The Price per Share of Harrow is $31.75. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Harrow.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Harrow, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.53. Based on the TTM, the Book Value Change Per Share is $-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is $0.26 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Harrow.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.48-1.5%-0.15-0.5%-0.21-0.7%-0.16-0.5%-0.11-0.4%-0.08-0.3%
Usd Book Value Change Per Share-0.36-1.1%-0.02-0.1%0.260.8%0.110.3%0.060.2%0.030.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.36-1.1%-0.02-0.1%0.260.8%0.110.3%0.060.2%0.040.1%
Usd Price Per Share26.60-31.50-14.46-19.93-14.87-9.67-
Price to Earnings Ratio-13.73--23.92--22.88--9.66--2.34--3.31-
Price-to-Total Gains Ratio-73.95--856.82-304.99--208.84--101.00--66.66-
Price to Book Ratio17.40-19.25-13.17-62.44-43.92-47.97-
Price-to-Total Gains Ratio-73.95--856.82-304.99--208.84--101.00--66.66-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share31.75
Number of shares31
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.06
Usd Total Gains Per Share-0.020.06
Gains per Quarter (31 shares)-0.771.78
Gains per Year (31 shares)-3.087.13
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-3-1307-3
20-6-160144
30-9-1912111
40-12-2212818
50-15-2513525
60-18-2814232
70-22-3114939
80-25-3425646
90-28-3726253
100-31-4026960

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%10.030.00.025.0%10.066.00.013.2%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%8.012.00.040.0%16.024.00.040.0%23.052.01.030.3%
Dividend per Share0.00.04.00.0%1.00.011.08.3%7.00.013.035.0%9.00.031.022.5%14.00.062.018.4%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%8.012.00.040.0%16.024.00.040.0%23.052.01.030.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Harrow Health Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.360-0.025-93%0.260-238%0.105-442%0.056-743%0.034-1158%
Book Value Per Share--1.5291.643-7%1.548-1%1.188+29%0.923+66%0.612+150%
Current Ratio--0.9071.783-49%3.557-75%3.260-72%4.268-79%3.211-72%
Debt To Asset Ratio--0.8460.829+2%0.803+5%0.8490%0.796+6%0.768+10%
Debt To Equity Ratio--5.4574.840+13%4.826+13%12.441-56%9.013-39%12.410-56%
Dividend Per Share----0%-0%0.001-100%0.002-100%0.002-100%
Enterprise Value--734867360.000927894650.000-21%370030716.000+99%576621029.667+27%447901652.800+64%301171156.100+144%
Eps---0.484-0.148-69%-0.213-56%-0.162-67%-0.113-77%-0.085-82%
Ev To Ebitda Ratio---29.05128.195-203%-2.911-90%33.053-188%25.958-212%46.655-162%
Ev To Sales Ratio--3.8414.422-13%2.690+43%3.932-2%3.976-3%5.602-31%
Free Cash Flow Per Share--0.530-0.249+147%-0.097+118%-0.447+184%-0.301+157%-0.179+134%
Free Cash Flow To Equity Per Share--0.531-0.049+109%0.336+58%0.155+242%0.131+304%0.067+692%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.678+48%0.928+8%
Intrinsic Value_10Y_max--22.732----------
Intrinsic Value_10Y_min---5.157----------
Intrinsic Value_1Y_max---0.282----------
Intrinsic Value_1Y_min---1.581----------
Intrinsic Value_3Y_max--1.104----------
Intrinsic Value_3Y_min---3.856----------
Intrinsic Value_5Y_max--4.842----------
Intrinsic Value_5Y_min---5.135----------
Market Cap1165212300.000+16%976209360.0001156037400.000-16%530676216.000+84%731270113.000+33%545649652.800+79%354967706.100+175%
Net Profit Margin---0.372-0.122-67%-0.225-40%-0.178-52%-0.126-66%-0.322-13%
Operating Margin---0.235-0.006-97%-0.058-75%-0.049-79%-0.024-90%-0.309+32%
Operating Ratio--1.2350.995+24%1.051+18%1.013+22%0.999+24%1.251-1%
Pb Ratio20.772+16%17.40219.246-10%13.170+32%62.441-72%43.920-60%47.975-64%
Pe Ratio-16.384-19%-13.726-23.916+74%-22.879+67%-9.657-30%-2.336-83%-3.306-76%
Price Per Share31.750+16%26.60031.500-16%14.460+84%19.926+33%14.868+79%9.672+175%
Price To Free Cash Flow Ratio14.972+16%12.54429.022-57%8.242+52%6.117+105%5.026+150%-6.644+153%
Price To Total Gains Ratio-88.267-19%-73.950-856.820+1059%304.994-124%-208.840+182%-100.997+37%-66.659-10%
Quick Ratio--0.7701.555-50%3.059-75%2.890-73%4.491-83%3.427-78%
Return On Assets---0.049-0.016-67%-0.027-44%-0.027-44%-0.018-63%-0.064+32%
Return On Equity---0.315-0.100-68%-0.151-52%-0.639+103%-0.440+40%-1.518+382%
Total Gains Per Share---0.360-0.025-93%0.260-238%0.106-438%0.058-725%0.036-1105%
Usd Book Value--56096000.00060297750.000-7%56798500.000-1%43587833.333+29%33891250.000+66%22453200.000+150%
Usd Book Value Change Per Share---0.360-0.025-93%0.260-238%0.105-442%0.056-743%0.034-1158%
Usd Book Value Per Share--1.5291.643-7%1.548-1%1.188+29%0.923+66%0.612+150%
Usd Dividend Per Share----0%-0%0.001-100%0.002-100%0.002-100%
Usd Enterprise Value--734867360.000927894650.000-21%370030716.000+99%576621029.667+27%447901652.800+64%301171156.100+144%
Usd Eps---0.484-0.148-69%-0.213-56%-0.162-67%-0.113-77%-0.085-82%
Usd Free Cash Flow--19456000.000-9152000.000+147%-3566750.000+118%-16390333.333+184%-11041400.000+157%-6557625.000+134%
Usd Free Cash Flow Per Share--0.530-0.249+147%-0.097+118%-0.447+184%-0.301+157%-0.179+134%
Usd Free Cash Flow To Equity Per Share--0.531-0.049+109%0.336+58%0.155+242%0.131+304%0.067+692%
Usd Market Cap1165212300.000+16%976209360.0001156037400.000-16%530676216.000+84%731270113.000+33%545649652.800+79%354967706.100+175%
Usd Price Per Share31.750+16%26.60031.500-16%14.460+84%19.926+33%14.868+79%9.672+175%
Usd Profit---17780000.000-5424000.000-69%-7833250.000-56%-5943333.333-67%-4103800.000-77%-3101700.000-83%
Usd Revenue--47831000.00053214500.000-10%34669250.000+38%37009416.667+29%28788150.000+66%18374650.000+160%
Usd Total Gains Per Share---0.360-0.025-93%0.260-238%0.106-438%0.058-725%0.036-1105%
 EOD+4 -4MRQTTM+9 -28YOY+12 -253Y+20 -195Y+20 -2010Y+22 -18

3.3 Fundamental Score

Let's check the fundamental score of Harrow Health Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-16.384
Price to Book Ratio (EOD)Between0-120.772
Net Profit Margin (MRQ)Greater than0-0.372
Operating Margin (MRQ)Greater than0-0.235
Quick Ratio (MRQ)Greater than10.770
Current Ratio (MRQ)Greater than10.907
Debt to Asset Ratio (MRQ)Less than10.846
Debt to Equity Ratio (MRQ)Less than15.457
Return on Equity (MRQ)Greater than0.15-0.315
Return on Assets (MRQ)Greater than0.05-0.049
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Harrow Health Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.194
Ma 20Greater thanMa 5030.848
Ma 50Greater thanMa 10028.020
Ma 100Greater thanMa 20027.155
OpenGreater thanClose30.900
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Harrow Health Inc

Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE; MAXITROL eye drops; ILEVRO and NEVANAC, a non-steroidal and anti-inflammatory eye drop for pain and inflammation associated with cataract surgery; VIGAMOX, a fluoroquinolone antibiotic eye drop for the treatment of bacterial conjunctivitis; MAXIDEX and FLAREX, a steroid eye drop for steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe and the eye; TRIESENCE, a steroid injection for the treatment of ophthalmic diseases and for visualization during vitrectomy; and NATACYN, a sterile, antifungal drug for the treatment of fungal blepharitis, conjunctivitis, and keratitis. In addition, it offers TOBRADEX ST, a tobramycin and dexamethasone ophthalmic suspension; VERKAZIA cyclosporine ophthalmic emulsion; NEVANAC, a non-steroidal, anti-inflammatory eye drop; and FRESHKOTE preservative free (PF) is a lubricant eye drop. The company was formerly known as Harrow Health, Inc. and changed its name to Harrow, Inc. in September 2023. Harrow, Inc. was founded in 1998 and is headquartered in Nashville, Tennessee.

Fundamental data was last updated by Penke on 2025-06-19 08:30:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Harrow earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Harrow to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -37.2% means that $-0.37 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Harrow Health Inc:

  • The MRQ is -37.2%. The company is making a huge loss. -2
  • The TTM is -12.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-37.2%TTM-12.2%-25.0%
TTM-12.2%YOY-22.5%+10.3%
TTM-12.2%5Y-12.6%+0.4%
5Y-12.6%10Y-32.2%+19.5%
4.3.1.2. Return on Assets

Shows how efficient Harrow is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Harrow to the Drug Manufacturers - Specialty & Generic industry mean.
  • -4.9% Return on Assets means that Harrow generated $-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Harrow Health Inc:

  • The MRQ is -4.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.9%TTM-1.6%-3.3%
TTM-1.6%YOY-2.7%+1.1%
TTM-1.6%5Y-1.8%+0.2%
5Y-1.8%10Y-6.4%+4.6%
4.3.1.3. Return on Equity

Shows how efficient Harrow is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Harrow to the Drug Manufacturers - Specialty & Generic industry mean.
  • -31.5% Return on Equity means Harrow generated $-0.31 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Harrow Health Inc:

  • The MRQ is -31.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -10.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-31.5%TTM-10.0%-21.5%
TTM-10.0%YOY-15.1%+5.1%
TTM-10.0%5Y-44.0%+33.9%
5Y-44.0%10Y-151.8%+107.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Harrow Health Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Harrow is operating .

  • Measures how much profit Harrow makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Harrow to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -23.5% means the company generated $-0.23  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Harrow Health Inc:

  • The MRQ is -23.5%. The company is operating very inefficient. -2
  • The TTM is -0.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-23.5%TTM-0.6%-22.8%
TTM-0.6%YOY-5.8%+5.2%
TTM-0.6%5Y-2.4%+1.7%
5Y-2.4%10Y-30.9%+28.5%
4.3.2.2. Operating Ratio

Measures how efficient Harrow is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.23 means that the operating costs are $1.23 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Harrow Health Inc:

  • The MRQ is 1.235. The company is inefficient in keeping operating costs low. -1
  • The TTM is 0.995. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ1.235TTM0.995+0.240
TTM0.995YOY1.051-0.056
TTM0.9955Y0.999-0.004
5Y0.99910Y1.251-0.252
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Harrow Health Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Harrow is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.91 means the company has $0.91 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Harrow Health Inc:

  • The MRQ is 0.907. The company is just not able to pay all its short-term debts. -1
  • The TTM is 1.783. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ0.907TTM1.783-0.877
TTM1.783YOY3.557-1.773
TTM1.7835Y4.268-2.485
5Y4.26810Y3.211+1.058
4.4.3.2. Quick Ratio

Measures if Harrow is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Harrow to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.77 means the company can pay off $0.77 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Harrow Health Inc:

  • The MRQ is 0.770. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.555. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.770TTM1.555-0.785
TTM1.555YOY3.059-1.504
TTM1.5555Y4.491-2.936
5Y4.49110Y3.427+1.065
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Harrow Health Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Harrow assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Harrow to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.85 means that Harrow assets are financed with 84.6% credit (debt) and the remaining percentage (100% - 84.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Harrow Health Inc:

  • The MRQ is 0.846. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.829. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.846TTM0.829+0.017
TTM0.829YOY0.803+0.026
TTM0.8295Y0.796+0.033
5Y0.79610Y0.768+0.027
4.5.4.2. Debt to Equity Ratio

Measures if Harrow is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Harrow to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 545.7% means that company has $5.46 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Harrow Health Inc:

  • The MRQ is 5.457. The company is unable to pay all its debts with equity. -1
  • The TTM is 4.840. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ5.457TTM4.840+0.617
TTM4.840YOY4.826+0.014
TTM4.8405Y9.013-4.172
5Y9.01310Y12.410-3.398
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Harrow generates.

  • Above 15 is considered overpriced but always compare Harrow to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -13.73 means the investor is paying $-13.73 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Harrow Health Inc:

  • The EOD is -16.384. Based on the earnings, the company is expensive. -2
  • The MRQ is -13.726. Based on the earnings, the company is expensive. -2
  • The TTM is -23.916. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-16.384MRQ-13.726-2.658
MRQ-13.726TTM-23.916+10.190
TTM-23.916YOY-22.879-1.037
TTM-23.9165Y-2.336-21.580
5Y-2.33610Y-3.306+0.970
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Harrow Health Inc:

  • The EOD is 14.972. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 12.544. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 29.022. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD14.972MRQ12.544+2.429
MRQ12.544TTM29.022-16.478
TTM29.022YOY8.242+20.780
TTM29.0225Y5.026+23.996
5Y5.02610Y-6.644+11.670
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Harrow is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Harrow Health Inc:

  • The EOD is 20.772. Based on the equity, the company is expensive. -2
  • The MRQ is 17.402. Based on the equity, the company is expensive. -2
  • The TTM is 19.246. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD20.772MRQ17.402+3.369
MRQ17.402TTM19.246-1.844
TTM19.246YOY13.170+6.076
TTM19.2465Y43.920-24.674
5Y43.92010Y47.975-4.055
4.6.2. Total Gains per Share

2.4. Latest News of Harrow Health Inc

Does Harrow Health Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Harrow Health Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-07-06
16:00
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROWRead
2025-06-10
19:51
Harrow wins new Outperform at William Blair after licensing deal for pain drugRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Harrow Health Inc.

4.8.1. Institutions holding Harrow Health Inc

Institutions are holding 57.375% of the shares of Harrow Health Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Opaleye Management Inc10.776723.42263955000-35000-0.8772
2025-03-31BlackRock Inc7.01110.00142573051346751.366
2025-03-31Private Capital Management, LLC5.15165.493189062719564411.5425
2025-03-31Vanguard Group Inc5.0830.00091865449-6651-0.3553
2025-03-31BRAIDWELL LP2.60720.8947956839498005.4904
2025-03-31State Street Corp2.1430.0009786483-41215-4.9795
2025-03-31Geode Capital Management, LLC2.10920.0016774079529717.3458
2024-12-31D. E. Shaw & Co LP1.81120.0164664714418966.7268
2025-03-31Marshall Wace Asset Management Ltd1.17080.01454296744296740
2024-12-31Stifel Financial Corp1.11210.01434081218570.2104
2025-03-31ING Investment Management LLC1.03940.01133814613722374035.5269
2025-03-31Royce & Associates, LP0.89130.09433270963500611.9847
2025-03-31Northern Trust Corp0.85490.0012313728-5356-1.6786
2025-03-31Rice Hall James & Associates, LLC0.8070.463296172-14339-4.6179
2025-03-31Citadel Advisors Llc0.74730.0014274240155638131.2271
2025-03-31Charles Schwab Investment Management Inc0.67820.0012248900-6318-2.4755
2025-03-31Renaissance Technologies Corp0.66860.0099245370-32300-11.6325
2025-03-31Morgan Stanley - Brokerage Accounts0.60720.00042228502063010.2018
2025-03-31Susquehanna International Group, LLP0.55940.0009205314186626998.6408
2025-03-31First Turn Management LLC0.51451.0126188829-116045-38.0633
Total 46.343731.456517007997+1318430+7.8%

4.9.2. Funds holding Harrow Health Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-04-30Vanguard Total Stock Mkt Idx Inv2.66620.001497848900
2025-05-31iShares Russell 2000 ETF2.07490.034876149000
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr1.32010.01184844646850.1416
2024-12-31Private Capital Management Value Focus1.17368.1652430698-60617-12.3377
2025-03-31Fidelity Small Cap Index0.82980.03353045158270.2723
2025-05-31iShares Russell 2000 Growth ETF0.72550.067826626000
2025-04-30Voya Small Cap Growth I0.63220.480823202688793.979
2025-03-31Voya Small Cap Growth0.61650.4972262552262550
2025-05-31State St Russell Sm/Mid Cp® Indx SL Cl I0.50940.012818694000
2025-04-30Fidelity Extended Market Index0.46870.011817202525931.5304
2025-04-30Vanguard Russell 2000 ETF0.41420.031915199485545.9635
2025-05-31Schwab US Small-Cap ETF™0.39310.0245144263-370-0.2558
2024-12-31Private Capital Value Equity0.38156.6425140000-86033-38.0621
2025-03-31Private Capital Management Value I0.33365.057912243000
2025-05-31FTGF RY US SmCp Opp A USD Dis(A)0.31070.391611402561755.7255
2025-05-31State St Russell Sm Cap® Indx SL Cl I0.29510.035210830000
2025-03-31Royce Small-Cap Opportunity Invmt0.29470.29431081363039239.0924
2025-05-31SPDR® S&P Pharmaceuticals ETF0.2822.079210348600
2025-04-30BlackRock Global Equity Mkt Netrl Instl0.25920.0495951213967271.5468
2025-04-30Vanguard Health Care ETF0.25780.012894603-891-0.933
Total 14.238823.93635225520+176121+3.4%

5.3. Insider Transactions

Insiders are holding 15.066% of the shares of Harrow Health Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-25Opaleye Management Inc.BUY200009.97
2024-04-23Opaleye Management Inc.BUY1171510.29
2024-04-19Opaleye Management Inc.BUY2940010.56
2024-03-28Opaleye Management Inc.BUY5000012.82
2024-03-22Mark L BaumBUY900011.59
2024-03-20Opaleye Management Inc.BUY506009.65
2023-11-16Mark L BaumBUY75008.11
2023-09-19Opaleye Management Inc.BUY1401714.65
2023-08-14Mark L BaumBUY580017.05
2023-08-14Martin A MakaryBUY2000016.92
2022-12-22Andrew R BollBUY250013.54
2022-12-22Horn R Lawrence VanBUY186013.42
2022-12-22Mark L BaumBUY2500013.39
2022-09-30Richard L Md LindstromSELL4000012.62
2022-09-28Opaleye Management Inc.BUY110859.77
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Net Working Capital  83,7052,13485,839-33,78252,05746,25198,308-115,759-17,451



5.2. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets364,164
Total Liabilities308,068
Total Stockholder Equity56,451
 As reported
Total Liabilities 308,068
Total Stockholder Equity+ 56,451
Total Assets = 364,164

Assets

Total Assets364,164
Total Current Assets169,535
Long-term Assets194,629
Total Current Assets
Cash And Cash Equivalents 66,726
Net Receivables 77,291
Inventory 10,716
Other Current Assets 14,802
Total Current Assets  (as reported)169,535
Total Current Assets  (calculated)169,535
+/-0
Long-term Assets
Property Plant Equipment 11,905
Goodwill 332
Intangible Assets 182,392
Long-term Assets  (as reported)194,629
Long-term Assets  (calculated)194,629
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities186,986
Long-term Liabilities121,082
Total Stockholder Equity56,451
Total Current Liabilities
Short-term Debt 108,924
Short Long Term Debt 108,313
Accounts payable 37,095
Other Current Liabilities 40,822
Total Current Liabilities  (as reported)186,986
Total Current Liabilities  (calculated)295,154
+/- 108,168
Long-term Liabilities
Long term Debt 112,501
Capital Lease Obligations 9,192
Long-term Liabilities  (as reported)121,082
Long-term Liabilities  (calculated)121,693
+/- 611
Total Stockholder Equity
Common Stock35
Retained Earnings -169,165
Other Stockholders Equity 225,581
Total Stockholder Equity (as reported)56,451
Total Stockholder Equity (calculated)56,451
+/-0
Other
Capital Stock35
Cash and Short Term Investments 66,726
Common Stock Shares Outstanding 35,826
Current Deferred Revenue145
Liabilities and Stockholders Equity 364,164
Net Debt 163,280
Net Invested Capital 277,265
Net Working Capital -17,451
Property Plant and Equipment Gross 23,231
Short Long Term Debt Total 230,006



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-30
> Total Assets 
28
28
27
27
25
5,009
4,241
3,744
7,182
5,989
5,336
4,355
2,975
2,125
1,672
1,018
1,242
579
352
133
76
77
161
225
7,895
11,464
10,706
19,247
18,376
17,403
15,761
14,452
13,879
12,408
10,242
9,375
16,854
15,021
14,131
25,306
22,049
21,517
27,247
25,879
27,596
26,211
23,917
21,199
26,328
28,289
49,451
66,510
65,157
54,698
59,085
46,893
49,454
59,470
57,474
56,252
106,966
102,801
98,329
97,595
98,062
98,992
157,023
217,498
223,989
286,065
311,755
295,068
306,630
351,539
388,971
364,164
364,164388,971351,539306,630295,068311,755286,065223,989217,498157,02398,99298,06297,59598,329102,801106,96656,25257,47459,47049,45446,89359,08554,69865,15766,51049,45128,28926,32821,19923,91726,21127,59625,87927,24721,51722,04925,30614,13115,02116,8549,37510,24212,40813,87914,45215,76117,40318,37619,24710,70611,4647,89522516177761333525791,2421,0181,6722,1252,9754,3555,3365,9897,1823,7444,2415,0092527272828
   > Total Current Assets 
28
28
27
27
25
5,009
4,241
3,744
7,179
5,986
5,333
4,353
2,973
2,124
1,671
1,017
1,241
579
352
133
76
77
161
210
7,881
11,451
10,693
19,029
18,361
17,384
15,734
14,418
12,830
11,269
9,056
4,608
12,009
9,365
5,873
14,926
9,443
8,950
14,753
13,601
10,359
10,104
8,806
7,394
8,728
11,684
32,843
38,505
38,119
32,374
36,767
25,808
30,369
40,977
40,131
40,636
93,474
91,126
60,662
62,315
64,703
64,074
118,260
51,687
60,296
110,278
139,073
124,990
139,390
147,062
189,651
169,535
169,535189,651147,062139,390124,990139,073110,27860,29651,687118,26064,07464,70362,31560,66291,12693,47440,63640,13140,97730,36925,80836,76732,37438,11938,50532,84311,6848,7287,3948,80610,10410,35913,60114,7538,9509,44314,9265,8739,36512,0094,6089,05611,26912,83014,41815,73417,38418,36119,02910,69311,4517,88121016177761333525791,2411,0171,6712,1242,9734,3535,3335,9867,1793,7444,2415,0092527272828
       Cash And Cash Equivalents 
28
28
27
27
17
4,298
3,706
3,408
6,711
5,776
5,111
4,193
2,902
1,999
1,590
952
1,043
467
291
71
6
2
146
147
7,717
10,991
10,036
19,029
17,970
16,828
15,579
14,201
12,102
10,364
8,211
2,898
10,051
6,556
2,685
11,821
5,441
2,362
8,853
7,396
4,165
3,867
4,019
2,692
4,170
6,315
6,638
4,265
3,993
3,431
4,749
3,924
3,902
5,527
4,101
6,304
72,651
57,656
42,167
41,948
46,438
44,959
96,270
19,248
22,754
65,610
74,085
68,538
70,968
72,601
47,247
66,726
66,72647,24772,60170,96868,53874,08565,61022,75419,24896,27044,95946,43841,94842,16757,65672,6516,3044,1015,5273,9023,9244,7493,4313,9934,2656,6386,3154,1702,6924,0193,8674,1657,3968,8532,3625,44111,8212,6856,55610,0512,8988,21110,36412,10214,20115,57916,82817,97019,02910,03610,9917,71714714626712914671,0439521,5901,9992,9024,1935,1115,7766,7113,4083,7064,2981727272828
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50
50
50
50
50
150
150
150
150
150
150
150
150
150
106
200
200
200
200
200
127
125
125
21,420
28,000
27,650
22,120
25,200
14,350
19,075
27,650
28,455
25,620
12,209
9,989
8,503
8,642
5,193
4,162
5,589
7,631
6,917
8,265
8,681
7,433
1,453
0
0
0
0001,4537,4338,6818,2656,9177,6315,5894,1625,1938,6428,5039,98912,20925,62028,45527,65019,07514,35025,20022,12027,65028,00021,4201251251272002002002002001061501501501501501501501501505050505050000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
81
68
81
436
579
701
840
943
1,922
3,074
2,921
3,036
2,856
2,625
1,624
1,611
1,583
1,781
1,964
2,921
2,987
3,516
2,009
2,783
2,803
3,010
2,662
3,253
3,710
17,802
4,518
6,065
6,864
6,882
6,388
12,309
18,258
18,696
36,489
29,188
52,216
53,734
116,601
77,291
77,291116,60153,73452,21629,18836,48918,69618,25812,3096,3886,8826,8646,0654,51817,8023,7103,2532,6623,0102,8032,7832,0093,5162,9872,9211,9641,7811,5831,6111,6242,6252,8563,0362,9213,0741,92294384070157943681688110000000000000000000000000000000
       Other Current Assets 
0
0
0
8
8
711
534
336
469
211
222
159
71
124
81
65
199
111
61
62
71
74
15
64
164
536
658
204
391
556
105
215
474
486
391
563
586
835
936
929
639
1,268
1,138
1,125
1,506
1,238
590
978
759
1,064
912
931
775
802
786
651
637
816
941
770
1,001
1,628
1,257
1,264
1,076
2,788
21,990
32,439
37,542
8,783
8,951
9,021
6,781
10,343
3,410
14,802
14,8023,41010,3436,7819,0218,9518,78337,54232,43921,9902,7881,0761,2641,2571,6281,0017709418166376517868027759319121,0647599785901,2381,5061,1251,1381,26863992993683558656339148647421510555639120465853616464157471626111119965811247115922221146933653471188000
   > Long-term Assets 
0
0
0
0
0
0
534
0
3
3
2
2
2
2
1
1
1
1
0
0
0
0
0
14
14
13
13
218
16
20
27
34
1,049
1,139
1,186
4,767
4,845
5,656
8,258
10,379
12,606
12,566
12,494
12,278
17,237
16,107
15,111
13,805
17,600
16,605
16,608
28,005
27,038
22,324
22,318
21,085
19,085
18,493
17,343
15,616
13,492
11,675
37,667
35,280
33,359
34,918
37,168
165,811
163,693
175,787
172,682
170,078
167,240
204,477
199,320
194,629
194,629199,320204,477167,240170,078172,682175,787163,693165,81137,16834,91833,35935,28037,66711,67513,49215,61617,34318,49319,08521,08522,31822,32427,03828,00516,60816,60517,60013,80515,11116,10717,23712,27812,49412,56612,60610,3798,2585,6564,8454,7671,1861,1391,04934272016218131314140000011112222330534000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
3
3
2
2
2
2
1
1
1
1
0
0
0
0
0
14
14
13
13
13
16
20
27
34
76
179
243
479
601
1,067
2,657
4,814
7,053
7,346
7,295
7,103
6,567
6,419
6,215
6,008
5,966
6,061
6,375
12,437
12,015
11,141
11,934
11,578
11,252
11,718
11,252
10,851
9,684
9,451
9,076
9,815
10,652
10,979
10,999
10,922
10,789
10,601
12,444
12,376
10,058
13,004
12,288
11,905
11,90512,28813,00410,05812,37612,44410,60110,78910,92210,99910,97910,6529,8159,0769,4519,68410,85111,25211,71811,25211,57811,93411,14112,01512,4376,3756,0615,9666,0086,2156,4196,5677,1037,2957,3467,0534,8142,6571,0676014792431797634272016131313141400000111122223300000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
332
332
332
1,134
1,180
1,419
2,466
2,466
2,466
2,227
2,227
2,227
2,227
2,227
2,227
2,227
2,227
2,227
2,227
2,227
2,227
332
332
332
332
332
332
332
332
332
332
332
332
332
332
332
332
332
332
332
332
332
332
332
3323323323323323323323323323323323323323323323323323323323323323323322,2272,2272,2272,2272,2272,2272,2272,2272,2272,2272,2272,2272,4662,4662,4661,4191,1801,13433233233200000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,509
4,577
3,809
2,694
6,513
5,353
4,947
10,229
9,642
8,560
7,715
6,830
5,541
4,485
3,820
2,521
1,594
0
11,133
8,247
5,601
2,097
0
0
0
0
0
0
0
0
0
0
00000000002,0975,6018,24711,13301,5942,5213,8204,4855,5416,8307,7158,5609,64210,2294,9475,3536,5132,6943,8094,5775,50900000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
642
628
611
3,154
3,064
3,170
3,135
3,099
3,087
2,993
2,972
2,948
2,934
2,884
2,860
2,876
2,894
2,964
3,059
3,112
3,154
2,291
2,337
2,345
1,960
1,958
1,939
1,912
1,882
1,892
17,126
16,886
16,774
21,510
25,837
154,269
150,148
164,854
162,044
159,389
156,850
189,272
186,700
182,392
182,392186,700189,272156,850159,389162,044164,854150,148154,26925,83721,51016,77416,88617,1261,8921,8821,9121,9391,9581,9602,3452,3372,2913,1543,1123,0592,9642,8942,8762,8602,8842,9342,9482,9722,9933,0873,0993,1353,1703,0643,15461162864200000000000000000000000000000000
       Other Assets 
0
0
0
0
6
6
-534
336
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
973
960
943
4,288
4,244
4,589
5,601
1
5,553
1
5,199
5,175
10,670
9,688
8,896
256
11,634
10,544
0
0
0
0
0
0
0
0
11
0
0
0
0
0
0
0
1,595
0
288
0
0
0
0
0
0
0
000000028801,5950000000110000000010,54411,6342568,8969,68810,6705,1755,19915,55315,6014,5894,2444,288943960973000000000000000000000000336-534660000
> Total Liabilities 
1
1
3
5
4
243
750
471
921
607
764
1,245
1,029
901
1,095
1,054
1,469
1,400
1,391
1,535
1,599
1,648
1,861
930
491
670
710
849
1,108
1,059
651
655
1,835
2,124
2,092
3,169
11,614
12,777
15,516
16,522
16,441
18,685
20,815
20,562
19,950
22,465
21,302
21,116
22,596
23,836
24,700
29,476
30,159
30,971
31,667
31,865
34,058
34,542
30,646
28,382
84,118
86,567
87,398
87,859
92,668
98,130
130,138
195,970
201,937
210,663
241,753
235,330
248,453
293,918
319,674
308,068
308,068319,674293,918248,453235,330241,753210,663201,937195,970130,13898,13092,66887,85987,39886,56784,11828,38230,64634,54234,05831,86531,66730,97130,15929,47624,70023,83622,59621,11621,30222,46519,95020,56220,81518,68516,44116,52215,51612,77711,6143,1692,0922,1241,8356556511,0591,1088497106704919301,8611,6481,5991,5351,3911,4001,4691,0541,0959011,0291,24576460792147175024345311
   > Total Current Liabilities 
1
1
3
5
4
243
750
471
921
607
764
1,245
1,029
901
1,095
1,054
452
363
335
461
1,599
1,648
1,861
930
491
670
710
849
1,108
1,059
651
655
1,342
1,577
1,560
2,236
2,667
3,742
5,374
5,670
5,325
5,780
9,905
11,795
5,517
6,053
5,774
5,904
8,159
10,368
11,901
11,210
9,856
11,428
12,284
13,224
13,083
13,782
10,799
10,074
8,144
10,477
9,722
9,182
12,922
18,371
18,632
17,708
23,011
19,029
49,344
41,753
53,551
95,005
91,343
186,986
186,98691,34395,00553,55141,75349,34419,02923,01117,70818,63218,37112,9229,1829,72210,4778,14410,07410,79913,78213,08313,22412,28411,4289,85611,21011,90110,3688,1595,9045,7746,0535,51711,7959,9055,7805,3255,6705,3743,7422,6672,2361,5601,5771,3426556511,0591,1088497106704919301,8611,6481,5994613353634521,0541,0959011,0291,24576460792147175024345311
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,093
1,112
1,430
609
0
0
0
345
0
0
0
0
6
24
22
27
510
510
504
15
8
868
4,889
7,169
1,052
1,124
651
1,542
2,340
3,495
3,969
4,680
1,979
2,009
2,408
3,828
4,740
4,922
4,486
3,869
986
792
280
906
1,266
1,406
723
744
764
1,570
806
795
1,534
1,014
497
108,924
108,9244971,0141,5347958061,5707647447231,4061,2669062807929863,8694,4864,9224,7403,8282,4082,0091,9794,6803,9693,4952,3401,5426511,1241,0527,1694,889868815504510510272224600003450006091,4301,1121,09300000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
53
270
992
1,729
2,529
2,552
247
1,007
1,772
2,546
3,422
3,750
3,898
2,659
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
108,313
108,3130000000000000002,6593,8983,7503,4222,5461,7721,0072472,5522,5291,729992270530000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
201
201
696
428
879
524
556
781
603
427
681
560
122
76
74
161
406
436
275
257
424
595
342
849
765
698
262
357
750
804
787
1,145
1,181
1,917
3,407
4,253
3,956
3,795
3,538
3,920
3,344
4,035
3,885
3,883
4,663
5,931
4,966
6,143
6,943
8,144
7,409
7,300
5,530
5,511
3,645
4,941
3,882
4,671
5,174
5,595
8,038
7,043
18,632
13,794
10,506
6,025
21,424
12,567
20,177
25,277
38,762
37,095
37,09538,76225,27720,17712,56721,4246,02510,50613,79418,6327,0438,0385,5955,1744,6713,8824,9413,6455,5115,5307,3007,4098,1446,9436,1434,9665,9314,6633,8833,8854,0353,3443,9203,5383,7953,9564,2533,4071,9171,1811,14578780475035726269876584934259542425727543640616174761225606814276037815565248794286962012010000
       Other Current Liabilities 
1
1
3
5
4
42
54
44
41
84
208
464
425
474
414
494
329
287
261
300
100
100
56
65
68
75
367
-1
341
358
389
298
585
747
747
1,047
903
1,294
1,398
1,352
1,335
1,062
1,387
698
1,113
886
1,238
-230
448
-39
2,847
-1,036
-156
726
2,703
1,622
2,351
2,880
2,889
891
4,052
5,011
4,252
3,368
4,065
9,807
-836
3,103
11,609
10,060
27,039
28,279
31,592
93,854
52,084
40,822
40,82252,08493,85431,59228,27927,03910,06011,6093,103-8369,8074,0653,3684,2525,0114,0528912,8892,8802,3511,6222,703726-156-1,0362,847-39448-2301,2388861,1136981,3871,0621,3351,3521,3981,2949031,047747747585298389358341-136775686556100100300261287329494414474425464208844144544245311
   > Long-term Liabilities 
0
0
3,075
4,950
201
42,128
54
44
41
84
698
464
425
474
681
494
1,018
1,037
0
0
0
0
1,074
257
424
595
287
504
766
700
262
357
493
546
532
933
8,947
9,035
10,142
10,852
11,116
12,905
10,910
8,767
14,433
16,412
15,528
15,212
14,437
13,468
12,799
18,266
20,303
19,543
19,383
18,641
20,975
20,760
19,847
18,308
75,974
76,090
77,676
78,677
79,746
79,759
111,506
178,262
178,926
191,634
192,409
193,577
194,902
198,913
228,331
121,082
121,082228,331198,913194,902193,577192,409191,634178,926178,262111,50679,75979,74678,67777,67676,09075,97418,30819,84720,76020,97518,64119,38319,54320,30318,26612,79913,46814,43715,21215,52816,41214,4338,76710,91012,90511,11610,85210,1429,0358,9479335325464933572627007665042875954242571,07400001,0371,0184946814744254646988441445442,1282014,9503,07500
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
25
19
12
8,069
8,218
8,337
9,099
9,413
11,169
9,255
7,192
12,886
14,760
14,728
14,412
13,637
12,668
11,999
11,383
13,498
12,865
12,219
11,605
14,127
13,160
12,378
10,996
71,265
71,457
71,654
71,847
72,042
72,239
104,174
168,850
169,712
0
0
0
0
0
0
0
0000000169,712168,850104,17472,23972,04271,84771,65471,45771,26510,99612,37813,16014,12711,60512,21912,86513,49811,38311,99912,66813,63714,41214,72814,76012,8867,1929,25511,1699,4139,0998,3378,2188,0691219251000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
55
0
0
0
0
0
0
0
0
0
0
0
0
0
483
522
513
921
878
817
888
887
887
972
1,745
667
667
800
800
800
810
800
800
800
800
800
800
800
800
800
800
800
0
0
0
0
0
0
0
0
2,275
0
0
0
0
0
0
0
00000002,275000000008008008008008008008008008008008008108008008006676671,745972887887888817878921513522483000000000000055000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
403
355
306
1,305
1,253
1,203
1,151
988
908
880
852
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,950
0
0
0
0
0
0
0
0
0
0000000001,950000000000000000000008528809089881,1511,2031,2531,30530635540300000000000000000000000000000000000
> Total Stockholder Equity
27
27
24
22
21
4,766
3,490
3,273
6,262
5,382
4,572
3,110
1,947
1,224
577
-36
-227
-820
0
0
-1,523
-1,571
-1,700
-706
7,404
10,794
9,996
18,398
17,269
16,345
15,111
13,796
12,044
10,284
8,150
6,206
5,240
2,244
-1,385
8,784
5,608
2,832
6,432
5,317
7,646
3,746
2,615
83
3,732
4,453
24,751
37,059
35,065
23,955
27,711
15,337
15,728
25,275
27,183
28,225
23,203
16,589
11,286
10,091
5,749
1,217
27,240
21,528
22,052
75,402
70,357
60,093
58,532
57,976
69,652
56,451
56,45169,65257,97658,53260,09370,35775,40222,05221,52827,2401,2175,74910,09111,28616,58923,20328,22527,18325,27515,72815,33727,71123,95535,06537,05924,7514,4533,732832,6153,7467,6465,3176,4322,8325,6088,784-1,3852,2445,2406,2068,15010,28412,04413,79615,11116,34517,26918,3989,99610,7947,404-706-1,700-1,571-1,52300-820-227-365771,2241,9473,1104,5725,3826,2623,2733,4904,7662122242727
   Common Stock
2
2
2
2
2
14
14
14
16
15
16
16
16
16
16
16
16
16
16
16
16
16
16
11
30
34
7
9
9
9
9
9
9
9
9
9
10
10
10
13
13
13
19
20
20
20
21
21
21
23
24
25
25
25
26
26
26
26
26
26
27
27
27
27
27
27
30
30
30
35
35
35
35
35
35,000,000
35
3535,000,0003535353535303030272727272727262626262626252525242321212120202019131313101010999999999734301116161616161616161616161616151614141422222
   Retained Earnings -169,165-151,385-158,162-153,942-147,469-133,904-124,756-120,365-116,136-109,493-110,548-104,084-97,845-95,407-87,989-79,661-77,183-77,400-78,549-87,187-86,950-74,043-76,700-65,231-62,853-74,211-92,341-89,827-92,349-88,836-86,065-80,373-81,857-76,851-70,749-66,899-62,260-57,764-52,640-48,688-44,958-41,865-39,120-36,668-34,073-31,747-29,865-27,788-25,570-24,104-22,651-21,405-19,900-18,521-18,149-18,064-17,899-17,467-17,041-16,294-15,806-14,936-14,160-13,231-12,003-10,382-9,429-8,614-7,350-7,078-5,558-60-59-57-54-54
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,525
16,562
16,805
19,183
28,780
33,412
34,094
43,959
45,047
46,201
46,849
47,860
48,703
49,395
50,006
51,155
53,918
54,874
56,369
71,031
72,494
73,568
83,264
87,154
87,999
89,791
91,430
92,411
93,538
96,771
98,938
99,887
100,271
100,630
101,728
102,261
102,889
103,798
104,557
105,382
102,837
104,551
106,666
107,909
109,806
111,738
137,058
137,989
142,742
0
0
0
0
0
0
0
0000000142,742137,989137,058111,738109,806107,909106,666104,551102,837105,382104,557103,798102,889102,261101,728100,630100,27199,88798,93896,77193,53892,41191,43089,79187,99987,15483,26473,56872,49471,03156,36954,87453,91851,15550,00649,39548,70347,86046,84946,20145,04743,95934,09433,41228,78019,18316,80516,56216,52500000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
80
80
80
80
80
10,310
10,554
10,610
14,860
14,795
14,938
15,097
15,162
15,368
15,497
15,755
16,051
16,204
0
0
0
0
16,821
19,194
28,780
33,412
34,094
43,959
45,047
46,201
46,849
47,860
48,703
49,395
50,006
51,155
53,918
54,874
56,369
71,031
72,494
73,568
83,264
87,154
87,999
89,791
91,430
92,411
93,538
96,771
98,938
99,887
100,271
100,630
101,728
102,261
102,889
103,798
104,557
105,382
102,837
104,551
106,666
107,909
109,806
111,738
136,703
137,634
142,387
200,478
204,226
207,995
212,439
216,103
221,002
225,581
225,581221,002216,103212,439207,995204,226200,478142,387137,634136,703111,738109,806107,909106,666104,551102,837105,382104,557103,798102,889102,261101,728100,630100,27199,88798,93896,77193,53892,41191,43089,79187,99987,15483,26473,56872,49471,03156,36954,87453,91851,15550,00649,39548,70347,86046,84946,20145,04743,95934,09433,41228,78019,19416,821000016,20416,05115,75515,49715,36815,16215,09714,93814,79514,86010,61010,55410,3108080808080



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue199,614
Cost of Revenue-49,245
Gross Profit150,369150,369
 
Operating Income (+$)
Gross Profit150,369
Operating Expense-142,016
Operating Income8,8228,353
 
Operating Expense (+$)
Research Development12,230
Selling General Administrative129,064
Selling And Marketing Expenses0
Operating Expense142,016141,294
 
Net Interest Income (+$)
Interest Income0
Interest Expense-22,786
Other Finance Cost-0
Net Interest Income-22,786
 
Pretax Income (+$)
Operating Income8,822
Net Interest Income-22,786
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-18,04235,686
EBIT - interestExpense = -17,320
-161,017,481
5,305
Interest Expense22,786
Earnings Before Interest and Taxes (EBIT)5,4664,744
Earnings Before Interest and Taxes (EBITDA)20,003
 
After tax Income (+$)
Income Before Tax-18,042
Tax Provision-161
Net Income From Continuing Ops-17,481-18,203
Net Income-17,481
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses190,792
Total Other Income/Expenses Net-26,86422,786
 

Technical Analysis of Harrow
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Harrow. The general trend of Harrow is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Harrow's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Harrow Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Harrow Health Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 32.38 < 32.45 < 32.50.

The bearish price targets are: 29.71 > 28.48 > 25.21.

Know someone who trades $HROW? Share this with them.👇

Harrow Health Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Harrow Health Inc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Harrow Health Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Harrow Health Inc. The current macd is 0.84795584.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Harrow price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Harrow. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Harrow price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Harrow Health Inc Daily Moving Average Convergence/Divergence (MACD) ChartHarrow Health Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Harrow Health Inc. The current adx is 17.31.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Harrow shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Harrow Health Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Harrow Health Inc. The current sar is 29.78.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Harrow Health Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Harrow Health Inc. The current rsi is 60.19. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Harrow Health Inc Daily Relative Strength Index (RSI) ChartHarrow Health Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Harrow Health Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Harrow price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Harrow Health Inc Daily Stochastic Oscillator ChartHarrow Health Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Harrow Health Inc. The current cci is 100.69.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Harrow Health Inc Daily Commodity Channel Index (CCI) ChartHarrow Health Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Harrow Health Inc. The current cmo is 22.64.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Harrow Health Inc Daily Chande Momentum Oscillator (CMO) ChartHarrow Health Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Harrow Health Inc. The current willr is -23.59550562.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Harrow is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Harrow Health Inc Daily Williams %R ChartHarrow Health Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Harrow Health Inc.

Harrow Health Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Harrow Health Inc. The current atr is 1.44927337.

Harrow Health Inc Daily Average True Range (ATR) ChartHarrow Health Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Harrow Health Inc. The current obv is 1,262,661.

Harrow Health Inc Daily On-Balance Volume (OBV) ChartHarrow Health Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Harrow Health Inc. The current mfi is 37.22.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Harrow Health Inc Daily Money Flow Index (MFI) ChartHarrow Health Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Harrow Health Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-10STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-12MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-14STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-02BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Harrow Health Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Harrow Health Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.194
Ma 20Greater thanMa 5030.848
Ma 50Greater thanMa 10028.020
Ma 100Greater thanMa 20027.155
OpenGreater thanClose30.900
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Harrow with someone you think should read this too:
  • Are you bullish or bearish on Harrow? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Harrow? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Harrow Health Inc

I send you an email if I find something interesting about Harrow Health Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Harrow Health Inc.

Receive notifications about Harrow Health Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.